Skip to main content
SleepCited

Kava für Insomnie

A

Based on 34 studies (8 meta-analyses, 1 RCT) with 4,679 total participants. Results are mixed across studies.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dkava\u0026condition\u003Dinsomnia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Fazit

Based on 34 studies (8 meta-analyses, 1 RCT) with 4,679 total participants. Results are mixed across studies.

Key Study Findings

Case Reports n=1 6 weeks
Diagnosing Acute Kava Dermopathy: A Case Report of a Characteristic Cutaneous Eruption.
Dose: None vs.: None Outcome: acute kava dermopathy with sebaceous gland necrosis Wirkung: None None

Population: 41-year-old Australian woman consuming kava for anxiety and insomnia

Case Reports n=1 Open-label
Severe kava withdrawal managed with phenobarbital.
Dose: None vs.: None Outcome: Resolution of kava withdrawal symptoms Wirkung: None None

Population: 45-year-old man with kava and kratom withdrawal

narrative review
Herbal and Natural Supplements for Improving Sleep: A Literature Review.
Dose: varies by supplement vs.: Placebo Wirkung: None None
Other Double-blind
The potential of AB-free kava in enabling tobacco cessation via management of abstinence-related stress and …
Dose: AB-free kava extract vs.: Placebo Outcome: Tobacco cessation via stress/insomnia management Wirkung: None None

Population: Adult smokers (trial protocol)

Key Statistics

34

Studien

4679

Teilnehmer

Mixed

A

Bewertung

Referenced Papers

Naunyn-Schmiedeberg's archives of … 2025 4 Zitierungen
The American journal … 2025 1 Zitierungen
Psychiatry investigation 2024 24 Zitierungen
Journal of psychosocial … 2022 2 Zitierungen
Combinatorial chemistry & … 2021 16 Zitierungen
Chemical research in … 2019 6 Zitierungen
Journal of medicinal … 2018 19 Zitierungen
Sleep medicine reviews 2015 152 Zitierungen
Advances in pharmacological … 2011 79 Zitierungen
Journal of psychopharmacology … 2005 176 Zitierungen
Integrative cancer therapies 2004 59 Zitierungen
Human psychopharmacology 2003 45 Zitierungen
Primary care 2002 43 Zitierungen
Phytotherapy research : … 2001 74 Zitierungen
Psychosomatic medicine 1999 136 Zitierungen
Der Hautarzt; Zeitschrift … 1996 22 Zitierungen

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

sleep:
120-250 mg kavalactones/day, 1-2 hrs before bed

Obergrenze: 250 mg kavalactones/day (European guidelines); limited to 3 months continuous use

In der Forschung untersuchte Dosierungen

Dosierung Dauer Wirkung N
None 6 weeks Negative 1
None -- Positive --
None -- Positive 1
varies by supplement -- Positive --
AB-free kava extract -- Mixed --
various -- Mixed 17
None -- Mixed --
Various medicinal herbs: Silexan, Kava, Ginkgo biloba, Withania somnifera, Galphimia glauca, Passion -- Positive --

Beste Einnahmezeit: 1-2 hours before bed; avoid daily use beyond 3 months without medical supervision

Safety & Side Effects

Gemeldete Nebenwirkungen

  • Drowsiness and reduced coordination
  • Hepatotoxicity (rare but serious — consult healthcare provider)
  • Skin rash (kava dermopathy) with chronic high-dose use
  • GI discomfort

Bekannte Wechselwirkungen

  • Alcohol — increased hepatotoxicity risk and CNS depression
  • Hepatotoxic medications (acetaminophen, statins) — additive liver stress
  • Benzodiazepines and sedatives — additive CNS depression
  • CYP450 substrates (2E1, 1A2, 2D6) — kavalactones may inhibit metabolism
  • Levodopa and dopaminergic drugs — kava may reduce efficacy

Tolerierbare Höchstaufnahmemenge: 250 mg kavalactones/day (European guidelines); limited to 3 months continuous use

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does Kava help with Insomnie?
Based on 34 studies with 4,679 participants, there is strong evidence from multiple clinical trials that Kava may support Insomnie management. Our evidence grade is A (Strong Evidence).
How much Kava should I take for Insomnie?
Studies have used various dosages. A commonly studied range is 120-250 mg kavalactones/day, 1-2 hrs before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Kava?
Reported side effects may include Drowsiness and reduced coordination, Hepatotoxicity (rare but serious — consult healthcare provider), Skin rash (kava dermopathy) with chronic high-dose use, GI discomfort. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Kava and Insomnie?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 34 peer-reviewed studies with 4,679 total participants. The overall direction of effect is mixed.

Related Evidence

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.